MIRA
NASDAQ · Pharmaceuticals
Mira Pharmaceuticals Inc
$0.96
+0.01 (+0.97%)
Open$0.96
Previous Close$0.95
Day High$0.97
Day Low$0.95
52W High$2.45
52W Low$0.90
Volume—
Avg Volume96.8K
Market Cap40.02M
P/E Ratio—
EPS$-0.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,297.2% upside
Current
$0.96
$0.96
Target
$23.03
$23.03
$12.17
$23.03 avg
$29.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.23M | 13.68M | 17.07M |
| Net Income | 2.05M | 2.22M | 2.28M |
| Profit Margin | 13.5% | 16.2% | 13.3% |
| EBITDA | 4.17M | 3.79M | 4.72M |
| Free Cash Flow | 3.12M | 1.71M | 2.33M |
| Rev Growth | +3.2% | +10.2% | +2.3% |
| Debt/Equity | 0.43 | 0.37 | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |